Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

Rentokil Initial (NYSE:RTO) Stock Sees Unusually High Call Option Buying

Rentokil Initial logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

Rentokil Initial PLC (NYSE:RTO - Get Free Report) was the recipient of some unusual options trading on Monday. Traders acquired 6,014 call options on the stock. This is an increase of 2,296% compared to the average volume of 251 call options.

Rentokil Initial Stock Performance

NYSE RTO traded down $0.05 on Monday, reaching $21.04. The stock had a trading volume of 1,175,727 shares, compared to its average volume of 1,397,148. The business has a 50 day moving average price of $22.19 and a 200 day moving average price of $27.66. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.98 and a current ratio of 1.06. Rentokil Initial has a 1 year low of $19.50 and a 1 year high of $34.67.

Rentokil Initial Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Tuesday, September 22nd. Investors of record on Friday, August 14th were given a dividend of $0.2240 per share. The ex-dividend date of this dividend was Friday, August 14th. This is a drop from Rentokil Initial's previous dividend of $0.4120. This represents a yield of 188.0%.

Analyst Ratings Changes

A number of equities research analysts have commented on RTO shares. Morgan Stanley lowered Rentokil Initial from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, September 29th. The Goldman Sachs Group reaffirmed a "buy" rating on shares of Rentokil Initial in a research note on Monday, October 5th. Stifel Nicolaus upgraded Rentokil Initial from a "hold" rating to a "buy" rating in a report on Monday, October 5th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Rentokil Initial in a research report on Monday, August 3rd. Finally, Wall Street Zen cut shares of Rentokil Initial from a "buy" rating to a "hold" rating in a report on Monday, July 20th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Rentokil Initial presently has an average rating of "Hold" and an average target price of $31.90.

Get Our Latest Report on Rentokil Initial

Institutional Trading of Rentokil Initial

A number of institutional investors have recently added to or reduced their stakes in RTO. Vontobel Holding Ltd. bought a new stake in shares of Rentokil Initial during the 3rd quarter worth $346,000. Diversified Management Inc. bought a new position in Rentokil Initial in the 3rd quarter worth $289,000. Integrated Wealth Concepts LLC acquired a new position in Rentokil Initial during the 2nd quarter worth $57,000. NewEdge Advisors LLC lifted its position in Rentokil Initial by 332.7% during the 2nd quarter. NewEdge Advisors LLC now owns 39,213 shares of the company's stock worth $1,122,000 after acquiring an additional 30,151 shares during the last quarter. Finally, Continuum Advisory LLC bought a new stake in Rentokil Initial during the second quarter valued at about $42,000. 9.91% of the stock is currently owned by institutional investors and hedge funds.

Rentokil Initial Company Profile

(Get Free Report)

Rentokil Initial plc NYSE: RTO is a business services company headquartered in the United Kingdom. It provides pest control, hygiene, and workplace services to commercial, public-sector, and residential customers. Its offerings are designed to help organizations manage pests, maintain sanitary environments, and support health, safety, and workplace standards.

The company's pest control services address insects, rodents, and other pests, while its hygiene operations provide washroom services, sanitary products, air care, floor-care solutions, and related workplace services.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Rentokil Initial Right Now?

Before you consider Rentokil Initial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.

While Rentokil Initial currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines